The session — “FDA’s START Pilot Program in Action: Insights from Year One”—will spotlight Myrtelle’s experience in this bold regulatory initiative designed to fast-track therapies for rare and life-threatening diseases.
HiRO Partners with Monash Health to Speed Up Complex Clinical Trials HiRO has formalized a…
HiRO Partners with Monash Health to Speed Up Complex Clinical Trials HiRO has formalized a…